ID   FAA28_MYCTU             Reviewed;         580 AA.
AC   P9WQ59; L0TCP5; P96290; Q7D6E4;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   07-APR-2021, entry version 35.
DE   RecName: Full=Long-chain-fatty-acid--AMP ligase FadD28 {ECO:0000305};
DE            EC=6.2.1.49 {ECO:0000269|PubMed:24831705};
DE   AltName: Full=Acyl-AMP synthetase;
DE   AltName: Full=FAAL28 {ECO:0000303|PubMed:19182784};
DE   AltName: Full=Long-chain fatty acid adenylyltransferase FadD28 {ECO:0000305};
GN   Name=fadD28; Synonyms=acoas; OrderedLocusNames=Rv2941;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   FUNCTION IN THE BIOSYNTHESIS OF MYCOCEROSATES, PATHWAY, AND DISRUPTION
RP   PHENOTYPE.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=10573420; DOI=10.1038/47042;
RA   Cox J.S., Chen B., McNeil M., Jacobs W.R. Jr.;
RT   "Complex lipid determines tissue-specific replication of Mycobacterium
RT   tuberculosis in mice.";
RL   Nature 402:79-83(1999).
RN   [3]
RP   FUNCTION IN THE BIOSYNTHESIS OF MYCOCEROSATES, PATHWAY, AND DISRUPTION
RP   PHENOTYPE.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=11279114; DOI=10.1074/jbc.m100662200;
RA   Camacho L.R., Constant P., Raynaud C., Laneelle M.A., Triccas J.A.,
RA   Gicquel B., Daffe M., Guilhot C.;
RT   "Analysis of the phthiocerol dimycocerosate locus of Mycobacterium
RT   tuberculosis. Evidence that this lipid is involved in the cell wall
RT   permeability barrier.";
RL   J. Biol. Chem. 276:19845-19854(2001).
RN   [4]
RP   FUNCTION AS AN ACYL-AMP SYNTHETASE, AND CATALYTIC ACTIVITY.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=15042094; DOI=10.1038/nature02384;
RA   Trivedi O.A., Arora P., Sridharan V., Tickoo R., Mohanty D., Gokhale R.S.;
RT   "Enzymic activation and transfer of fatty acids as acyl-adenylates in
RT   mycobacteria.";
RL   Nature 428:441-445(2004).
RN   [5]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=Beijing GC1237;
RX   PubMed=20844580; DOI=10.1371/journal.ppat.1001100;
RA   Brodin P., Poquet Y., Levillain F., Peguillet I., Larrouy-Maumus G.,
RA   Gilleron M., Ewann F., Christophe T., Fenistein D., Jang J., Jang M.S.,
RA   Park S.J., Rauzier J., Carralot J.P., Shrimpton R., Genovesio A.,
RA   Gonzalo-Asensio J.A., Puzo G., Martin C., Brosch R., Stewart G.R.,
RA   Gicquel B., Neyrolles O.;
RT   "High content phenotypic cell-based visual screen identifies Mycobacterium
RT   tuberculosis acyltrehalose-containing glycolipids involved in phagosome
RT   remodeling.";
RL   PLoS Pathog. 6:E1001100-E1001100(2010).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [8]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=24831705; DOI=10.1016/j.ymben.2014.05.002;
RA   Menendez-Bravo S., Comba S., Sabatini M., Arabolaza A., Gramajo H.;
RT   "Expanding the chemical diversity of natural esters by engineering a
RT   polyketide-derived pathway into Escherichia coli.";
RL   Metab. Eng. 24:97-106(2014).
RN   [9]
RP   CRYSTALLIZATION OF THE N-TERMINAL DOMAIN.
RX   PubMed=16582482; DOI=10.1107/s1744309106005938;
RA   Goyal A., Yousuf M., Rajakumara E., Arora P., Gokhale R.S.,
RA   Sankaranarayanan R.;
RT   "Crystallization and preliminary X-ray crystallographic studies of the N-
RT   terminal domain of FadD28, a fatty-acyl AMP ligase from Mycobacterium
RT   tuberculosis.";
RL   Acta Crystallogr. F 62:350-352(2006).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 1-460, CATALYTIC ACTIVITY,
RP   ACTIVITY REGULATION, AND NOMENCLATURE.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=19182784; DOI=10.1038/nchembio.143;
RA   Arora P., Goyal A., Natarajan V.T., Rajakumara E., Verma P., Gupta R.,
RA   Yousuf M., Trivedi O.A., Mohanty D., Tyagi A., Sankaranarayanan R.,
RA   Gokhale R.S.;
RT   "Mechanistic and functional insights into fatty acid activation in
RT   Mycobacterium tuberculosis.";
RL   Nat. Chem. Biol. 5:166-173(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 1-460 OF MUTANT TRP-330,
RP   MUTAGENESIS OF ILE-227 AND GLY-330, AND SUBSTRATE SELECTIVITY.
RX   PubMed=22206988; DOI=10.1016/j.jmb.2011.12.031;
RA   Goyal A., Verma P., Anandhakrishnan M., Gokhale R.S., Sankaranarayanan R.;
RT   "Molecular basis of the functional divergence of fatty acyl-AMP ligase
RT   biosynthetic enzymes of Mycobacterium tuberculosis.";
RL   J. Mol. Biol. 416:221-238(2012).
CC   -!- FUNCTION: Involved in the biosynthesis of phthiocerol dimycocerosate
CC       (PDIM), a cell wall-associated lipid found only in pathogenic
CC       mycobacteria (PubMed:10573420, PubMed:11279114). Catalyzes the
CC       activation of long-chain fatty acids as acyl-adenylates (acyl-AMP),
CC       which are then transferred to the multifunctional polyketide synthase
CC       Mas for further chain extension (PubMed:24831705). Probably plays a
CC       role in host phagosome maturation arrest (Probable).
CC       {ECO:0000269|PubMed:10573420, ECO:0000269|PubMed:11279114,
CC       ECO:0000269|PubMed:24831705, ECO:0000305|PubMed:20844580}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain fatty acid + ATP + holo-[mycocerosate synthase] =
CC         AMP + diphosphate + long-chain fatty acyl-[mycocerosate synthase];
CC         Xref=Rhea:RHEA:10696, Rhea:RHEA-COMP:12641, Rhea:RHEA-COMP:13239,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57560,
CC         ChEBI:CHEBI:64479, ChEBI:CHEBI:133243, ChEBI:CHEBI:456215;
CC         EC=6.2.1.49; Evidence={ECO:0000269|PubMed:24831705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10697;
CC         Evidence={ECO:0000269|PubMed:24831705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain fatty acid + ATP + H(+) = a long-chain fatty
CC         acyl-AMP + diphosphate; Xref=Rhea:RHEA:52336, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57560,
CC         ChEBI:CHEBI:136562; Evidence={ECO:0000269|PubMed:24831705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52337;
CC         Evidence={ECO:0000269|PubMed:24831705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain fatty acyl-AMP + holo-[mycocerosate synthase] =
CC         AMP + H(+) + long-chain fatty acyl-[mycocerosate synthase];
CC         Xref=Rhea:RHEA:52340, Rhea:RHEA-COMP:12641, Rhea:RHEA-COMP:13239,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:64479, ChEBI:CHEBI:133243,
CC         ChEBI:CHEBI:136562, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:24831705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52341;
CC         Evidence={ECO:0000269|PubMed:24831705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + dodecanoate + H(+) = diphosphate + dodecanoyl-AMP;
CC         Xref=Rhea:RHEA:43712, ChEBI:CHEBI:15378, ChEBI:CHEBI:18262,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:83623;
CC         Evidence={ECO:0000269|PubMed:15042094, ECO:0000269|PubMed:19182784};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43713;
CC         Evidence={ECO:0000269|PubMed:15042094, ECO:0000269|PubMed:19182784};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H(+) + hexadecanoate = diphosphate + hexadecanoyl-AMP;
CC         Xref=Rhea:RHEA:43708, ChEBI:CHEBI:7896, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:83627;
CC         Evidence={ECO:0000269|PubMed:19182784};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43709;
CC         Evidence={ECO:0000269|PubMed:19182784};
CC   -!- ACTIVITY REGULATION: Inhibited by acylsulfamoyl (acyl-AMS) analogs.
CC       {ECO:0000269|PubMed:19182784}.
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000269|PubMed:10573420, ECO:0000269|PubMed:11279114}.
CC   -!- DISRUPTION PHENOTYPE: Disruption of fadD28 abolishes the production of
CC       phthiocerol dimycocerosate (DIM) on the cell envelope (PubMed:10573420,
CC       PubMed:11279114). Grows normally in liquid culture, traffics into host
CC       (human and mouse) acidified compartments early after phagocytosis,
CC       suggesting it no longer arrests phagosome maturation as well as wild-
CC       type, impaired growth in mouse macrophages (PubMed:20844580).
CC       {ECO:0000269|PubMed:10573420, ECO:0000269|PubMed:11279114,
CC       ECO:0000269|PubMed:20844580}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP45744.1; -; Genomic_DNA.
DR   PIR; B70668; B70668.
DR   RefSeq; NP_217457.1; NC_000962.3.
DR   RefSeq; WP_003414857.1; NZ_NVQJ01000015.1.
DR   PDB; 3E53; X-ray; 2.35 A; A=1-460.
DR   PDB; 3T5A; X-ray; 2.05 A; A=1-460.
DR   PDBsum; 3E53; -.
DR   PDBsum; 3T5A; -.
DR   SMR; P9WQ59; -.
DR   STRING; 83332.Rv2941; -.
DR   ChEMBL; CHEMBL5766; -.
DR   SwissLipids; SLP:000000975; -.
DR   PaxDb; P9WQ59; -.
DR   GeneID; 887454; -.
DR   KEGG; mtu:Rv2941; -.
DR   TubercuList; Rv2941; -.
DR   eggNOG; COG0318; Bacteria.
DR   OMA; MLATSSH; -.
DR   PhylomeDB; P9WQ59; -.
DR   Reactome; R-MTU-9635470; Dimycocersyl phthiocerol biosynthesis.
DR   UniPathway; UPA00094; -.
DR   PRO; PR:P9WQ59; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; HDA:MTBBASE.
DR   GO; GO:0070566; F:adenylyltransferase activity; IDA:MTBBASE.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004321; F:fatty-acyl-CoA synthase activity; IDA:MTBBASE.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051701; P:biological process involved in interaction with host; IMP:MTBBASE.
DR   GO; GO:0071770; P:DIM/DIP cell wall layer assembly; IMP:MTBBASE.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0008610; P:lipid biosynthetic process; IMP:MTBBASE.
DR   GO; GO:0052572; P:response to host immune response; IMP:MTBBASE.
DR   GO; GO:0052170; P:suppression by symbiont of host innate immune response; IDA:MTBBASE.
DR   CDD; cd05931; FAAL; 1.
DR   Gene3D; 3.40.50.12780; -; 1.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; AMP-dep_Synthh-like_sf.
DR   InterPro; IPR040097; FAAL/FAAC.
DR   Pfam; PF00501; AMP-binding; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Fatty acid metabolism; Ligase; Lipid metabolism;
KW   Nucleotide-binding; Reference proteome.
FT   CHAIN           1..580
FT                   /note="Long-chain-fatty-acid--AMP ligase FadD28"
FT                   /id="PRO_0000406355"
FT   SITE            227
FT                   /note="Important for substrate selectivity"
FT   SITE            330
FT                   /note="Important for substrate selectivity"
FT   MUTAGEN         227
FT                   /note="I->W: Shows substantial decrease (69%) in the
FT                   activity with lauric acid (C12 fatty acid) as substrate but
FT                   shows a 4-fold higher activity with the long chain fatty
FT                   acyl capric acid (C10 fatty acid) as substrate."
FT                   /evidence="ECO:0000269|PubMed:22206988"
FT   MUTAGEN         330
FT                   /note="G->W: No activity with lauric acid (C12 fatty acid)
FT                   as substrate. Instead, it catalyzes activation of acetic
FT                   acid (C2 fatty acid) as acetyl-AMP."
FT                   /evidence="ECO:0000269|PubMed:22206988"
FT   HELIX           6..16
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          20..27
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   TURN            28..30
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          35..40
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           41..55
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          64..68
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           73..84
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          88..92
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           103..111
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          114..118
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   TURN            120..122
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           123..128
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          140..143
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           144..146
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          164..169
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          181..184
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           185..199
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   TURN            201..205
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          211..215
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           224..228
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           230..235
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          239..241
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           244..249
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           252..257
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          260..268
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           270..279
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           283..285
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          295..298
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          300..302
FT                   /evidence="ECO:0007744|PDB:3E53"
FT   HELIX           305..314
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           316..318
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           322..324
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          325..331
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   TURN            332..335
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          336..340
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          349..352
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           354..358
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          367..369
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          371..374
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          380..387
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   TURN            389..391
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          401..407
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   HELIX           418..425
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          441..451
FT                   /evidence="ECO:0007744|PDB:3T5A"
FT   STRAND          454..459
FT                   /evidence="ECO:0007744|PDB:3T5A"
SQ   SEQUENCE   580 AA;  62641 MW;  60842A083746AFD3 CRC64;
     MSVRSLPAAL RACARLQPHD PAFTFMDYEQ DWDGVAITLT WSQLYRRTLN VAQELSRCGS
     TGDRVVISAP QGLEYVVAFL GALQAGRIAV PLSVPQGGVT DERSDSVLSD SSPVAILTTS
     SAVDDVVQHV ARRPGESPPS IIEVDLLDLD APNGYTFKED EYPSTAYLQY TSGSTRTPAG
     VVMSHQNVRV NFEQLMSGYF ADTDGIPPPN SALVSWLPFY HDMGLVIGIC APILGGYPAV
     LTSPVSFLQR PARWMHLMAS DFHAFSAAPN FAFELAARRT TDDDMAGRDL GNILTILSGS
     ERVQAATIKR FADRFARFNL QERVIRPSYG LAEATVYVAT SKPGQPPETV DFDTESLSAG
     HAKPCAGGGA TSLISYMLPR SPIVRIVDSD TCIECPDGTV GEIWVHGDNV ANGYWQKPDE
     SERTFGGKIV TPSPGTPEGP WLRTGDSGFV TDGKMFIIGR IKDLLIVYGR NHSPDDIEAT
     IQEITRGRCA AISVPGDRST EKLVAIIELK KRGDSDQDAM ARLGAIKREV TSALSSSHGL
     SVADLVLVAP GSIPITTSGK VRRGACVEQY RQDQFARLDA
//
